SAM
CORT icon

Shell Asset Management’s Corcept Therapeutics CORT Stock Holding History

Shell Asset Management’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$113K Sell
1,360
-1,878
-58% -$136K 0.01% 610
2025
Q2 		$238K Sell
3,238
-592
-15% -$42.9K 0.01% 709
2025
Q1 		$437K Sell
3,830
-4,680
-55% -$285K 0.02% 503
2024
Q4 		$429K Hold
8,510
– – 0.02% 545
2024
Q3 		$394K Buy
+8,510
New +$302K 0.02% 579
2024
Q1 		$292K Sell
9,001
-911
-9% -$21.5K 0.01% 690
2023
Q4 		$322K Sell
9,912
-2,964
-23% -$81.4K 0.01% 689
2023
Q3 		$351K Sell
12,876
-223
-2% -$6.45K 0.01% 703
2023
Q2 		$291K Sell
13,099
-4,743
-27% -$109K 0.01% 794
2023
Q1 		$386K Sell
17,842
-62
-0.3% -$1.36K 0.02% 672
2022
Q4 		$364K Sell
17,904
-3,732
-17% -$93.5K 0.02% 691
2022
Q3 		$555K Sell
21,636
-5,668
-21% -$152K 0.02% 522
2022
Q2 		$649K Buy
27,304
+48
+0.2% +$1.05K 0.02% 570
2022
Q1 		$614K Sell
27,256
-4,031
-13% -$85.7K 0.01% 707
2021
Q4 		$619K Buy
31,287
+150
+0.5% +$3.04K 0.01% 798
2021
Q3 		$613K Sell
31,137
-1,340
-4% -$28K 0.01% 772
2021
Q2 		$714K Buy
32,477
+8,106
+33% +$180K 0.01% 741
2021
Q1 		$580K Sell
24,371
-140
-0.6% -$3.74K 0.01% 783
2020
Q4 		$641K Hold
24,511
– – 0.01% 677
2020
Q3 		$427K Hold
24,511
– – 0.01% 747
2020
Q2 		$412K Buy
+24,511
New +$344K 0.01% 747

Other funds holding CORT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Shell Asset Management's CORT Position: Q3 2025 in Review

Shell Asset Management reduced its Corcept Therapeutics (CORT) stake by 58% in Q3 2025, selling an estimated $136K and leaving 1,360 shares worth $113K. The position accounts for 0.01% of the portfolio, ranked #610.

Shell Asset Management first reported a position in CORT in Q2 2020 and has held it in 21 quarters since. The position peaked at $714K in Q2 2021. 429 funds tracked by Wall St. Rank hold CORT as of Q3 2025.

  • Shell Asset Management held 1,360 shares of Corcept Therapeutics worth $113K as of Q3 2025.
  • Shell Asset Management sold 1,878 Corcept Therapeutics shares in Q3 2025, an estimated $136K.
  • Corcept Therapeutics made up 0.01% of Shell Asset Management's portfolio in Q3 2025, its #610 holding.
  • Shell Asset Management first reported a position in Corcept Therapeutics in Q2 2020 and has held it in 21 quarters since.
  • Shell Asset Management's Corcept Therapeutics position peaked at $714K in Q2 2021.
  • 429 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.